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Abstract Expression of mouse aldolase A L-type mRNA is
negatively modulated by a cis element (AldA-NRE), located
within the aldolase A distal promoter (pL). AldA-NRE interacts
with a 97-kDa repressor protein (p97), which binds DNA in a cell
cycle-dependent manner. We demonstrate that the binding
between AldA-NRE and p97 decreases during differentiation of
human Caco-2 cells and is inversely correlated with L-type
mRNA expression. Phosphorylation of the p97 repressor
weakened its DNA binding activity in differentiated Caco-2
cells, while dephosphorylation enhanced the binding in prolifer-
ating cells. Stimulation of protein kinase C (PKC) in vivo
decreased the binding of p97 to AldA-NRE and stimulated
transcription, while inhibition of PKC stimulated p97 binding
and downregulated transcription. These findings suggest that
PKC is a mediator of the binding and silencing function of the
p97/AldA-NRE repressor complex.
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1. Introduction
Transcription of the aldolase A gene is driven by three
autonomous promoters ^ distal (pL), middle (pM) and prox-
imal (pF) ^ and is modulated by interactions between nuclear
proteins and DNA cis elements located within the promoter
regions upstream of leader exons L1, M and F, depending on
cell and stage speci¢city [1^8]. Within the human pL promoter
we have identi¢ed a negative regulatory element (hAldA-
NRE) that binds a nuclear protein and acts as a true ‘silencer’
because it represses transcription in its own con¢guration and
transcription of a reporter gene driven by a heterologous pro-
moter [6,8]. Another negative regulatory transcriptional ele-
ment (reducing module) has been found to attenuate the prox-
imal promoter-driven transcription in the rat thymocyte
aldolase A gene [9]. However, this negative ‘reducing module’
is located in a position completely di¡erent from that of
AldA-NRE. In mouse and rat cells we found that L-type
mRNA expression is enhanced during growth arrest and at
the onset of the di¡erentiation programme [10]. Recently,
within the mouse distal promoter we detected a negative reg-
ulatory element (mAldA-NRE), highly homologous to the
human AldA-NRE, which binds a 97-kDa speci¢c nuclear
protein. We showed that an AGAGA DNA motif within
the AldA-NRE is the target for binding of the repressor
and that a dinucleotide (AA), adjacent to the GA-rich motif,
is required for silencing activity. Interestingly, the amount of
the silencer/repressor complex was greater in proliferating
NIH 3T3 cells than in serum-deprived cells and it was inverse-
ly correlated with expression of the L-type promoter, whose
transcription was downregulated in proliferating cells. These
¢ndings prompted the notion that AldA-NRE is involved in
the regulation of aldolase A L-type promoter activity through
its binding with a cell cycle-modulated repressor [11].
Here, we report that transcription of the human L-type
promoter is regulated by interaction between AldA-NRE
and a 97-kDa repressor (p97) in Caco-2 cells and that L-
type mRNA levels increase during cell di¡erentiation in cor-
respondence with a drastic decrease of the p97/AldA-NRE
complex. We demonstrate that a protein kinase C (PKC)-de-
pendent phosphorylation of p97 causes binding activity to
decrease. In fact, in cells stably expressing an AldA-CAT fu-
sion promoter construct, downregulation of PKC increased
p97 binding and drastically reduced transcriptional L-type
promoter activity. Conversely, PKC activation decreased the
binding and stimulated transcription of L-type promoter.
2. Materials and methods
2.1. Cell culture
The human colon carcinoma cell line Caco-2 was grown in Dulbec-
co’s modi¢ed Eagle’s medium (DMEM), supplemented with 10% foe-
tal calf serum (FCS). Cells were seeded at a density of about 500 000/
100 mm diameter dish, and routinely subcultured when the cells were
about 80% con£uent. The culture medium was changed every day.
Caco-2 cells di¡erentiate into enterocyte-like cells as a function of
cell density alone, without changes in the culture conditions [12].
Con£uence was reached within 6^8 days and the di¡erentiate state
on day 14^15. Mouse NIH 3T3 ¢broblasts were grown in DMEM
supplemented with 10% FCS. The medium was changed every 2^3
days, and the cultures were maintained strictly subcon£uent. Cells
were allowed to grow exponentially for 3 days. Thereafter cells were
maintained for 48 h in DMEM medium supplemented with 0.5% FCS
to achieve quiescence. Phorbol ester 12-O-tetradecanoylphorbol 13-
acetate (TPA) was added to the cells at a concentration of 120 ng/
ml for 10 min or at a concentration of 10 ng/ml for 1 h (PKC-stim-
ulating doses) or at a concentration of 200 ng/ml for 24 h (PKC-
inhibiting doses) [13,14].
2.2. RNase protection analysis
Total RNA was isolated by the method of Chomczynski and Sacchi
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[15]. RNase protection assays were performed as previously described
[10]. The human aldolase A L-type probe was obtained by transcrib-
ing with T7 RNA polymerase, in the presence of [K32P]CTP (400 Ci/
mmol; Amersham Corp.), a 150-bp fragment, which includes L1 and
L2 exons, cloned in the pGem4Z vector (Promega). The protected
fragments generated from this probe are 126 and 72 bp long.
2.3. Southwestern, EMSA and phosphatase assay
Nuclear protein extracts from NIH 3T3 and Caco-2 cells were pre-
pared according to Dignam et al. [16] modi¢ed as previously described
[11]. Southwestern experiments [11] and EMSA [1] were performed as
described. In phosphatase assay nuclear extracts (4 Wg) were incubated
with or without potato acid phosphatase (PAP) 0.06 and 0.12 U. for
20 min at 37‡C in Parker bu¡er 1U (glycerol 10%, HEPES 10 mM
(pH 7.9), KCl 100 mM, EDTA 0.1 mM, DTT 0.25 mM) prior to the
EMSA experiments. The phosphatase inhibitor 4-nitrophenylphos-
phate (4NPP) was added at concentrations of 1, 5 and 10 mM for
10 min prior to the addition of PAP. The speci¢c inhibitor of PKC 1-
(5-isoquinolinesulphonyl)-2-methylpiperazine (H7) was added to the
cell cultures at a concentration of 50 WM for 20 min prior to the
addition of TPA (120 ng/ml for 10 min). TPA, PAP, H7 and 4NPP
were purchased from Sigma-Aldrich.
2.4. Isolation of stable transfectants and CAT assays
To obtain NIH 3T3 cells permanently transfected with the L-type-
CAT fusion gene, 3U105 cells were cotransfected with 20 Wg of Ald-
ALv-555 plasmid or 20 Wg of AldALv-555MutN1 plasmid, previously
described [8,11], and 2 Wg of CMV-NEO plasmid by the calcium
phosphate technique [17]. After transfection, cells were cultured for
72 h in DMEM supplemented with 10% FCS; thereafter cells were
grown in selective medium containing G418 Geneticin (Gibco-BRL)
at a concentration of 800 Wg/ml. Selection continued for 3 weeks until
G418-resistant colonies were established. Several G418-resistant colo-
nies were selected and expanded in complete medium containing
300 Wg/ml of G418. One G418-resistant colony, clone 5, derived
from transfection with AldALv-555, and one colony, clone MN1,
derived from transfection with AldALv-555MutN1, were treated
with TPA, as described above, and used in CAT assays, performed
according to Gorman et al. [18].
3. Results
3.1. The binding e⁄ciency of the 97-kDa repressor to
AldA-NRE decreases during di¡erentiation of Caco-2 cells
We previously demonstrated that the expression of L-type
mRNA in NIH 3T3 cells is modulated by the interaction
between a cell cycle-dependent DNA binding protein of about
97 kDa and the mouse AldA-NRE [11]. Using EMSA and the
Southwestern technique we investigated whether a similar
DNA binding protein (p97) binds to the human AldA-NRE
and regulates L-type mRNA expression in Caco-2 cells (Fig.
1). We incubated the oligonucleotide Neg1 probe, which cov-
ers the sequence of AldA-NRE from 3510 to 3485 bp up-
stream of the initiation transcription site of L-type mRNA [8],
with nuclear extracts from undi¡erentiated and di¡erentiated
Caco-2 cells. These cells di¡erentiate spontaneously into en-
Fig. 1. Regulation of L-type mRNA expression in Caco-2 cells. A: Gel shift assay of nuclear extracts from undi¡erentiated Caco-2 cells at day
3 (lanes 2, 5 and 8), and di¡erentiated cells at day 7 (lanes 3, 6 and 9) and at day 15 (lanes 4, 7 and 10) of culture, using the 5P-end-labelled
probe Neg1. Speci¢c competition (lanes 5^7) was performed with a 200-fold molar excess of Neg1 oligonucleotide; non-speci¢c competition
(lanes 8^10) was performed with a 200-fold molar excess of unrelated oligonucleotide. Lane 1: the Neg1 probe alone. The arrow indicates the
speci¢c DNA-protein complex. F indicates the free probe. B: Southwestern assay of nuclear extracts from Caco-2 cells at day 3 (lane 1), day 7
(lane 2) and day 15 (lane 3), hybridised with probe Neg1. On the left is the molecular mass indicator. The asterisk indicates another complex
of lower molecular size that has a similar intensity in both undi¡erentiated and di¡erentiated cells. C: RNase protection assay on total RNA
from Caco-2 cells at day 3 (lane 1), day 7 (lane 2) and day 15 (lane 3), hybridised with riboprobe L. Two fragments of 72 and 126 bp, corre-
sponding to di¡erent initiation transcription sites of L-type mRNA, were protected by RNase digestion in the presence of L-type speci¢c probe.
The L-actin probe was added to each sample as internal control of the amounts of RNA used.
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terocyte-like cells under standard culture conditions, depend-
ing on cell density [12]. A retarded DNA-protein complex was
found in both undi¡erentiated (Fig. 1A, lane 2) and di¡er-
entiated cells at 7 and 15 days (Fig. 1A, lanes 3 and 4),
although the amount of DNA-protein complex decreased pro-
gressively during Caco-2 cell di¡erentiation. The same amount
of nuclear extracts tested for Sp1 DNA binding activity gave
retardation signals of the same intensity in both undi¡erenti-
ated and di¡erentiated cells (data not shown). Binding of un-
di¡erentiated and di¡erentiated cells was prevented by a 200-
fold molar excess of Neg1 oligonucleotide as speci¢c compet-
itor (Fig. 1A, lanes 5^7), whereas it was not a¡ected by a non-
speci¢c competitor (Fig. 1A, lanes 8^10). In Southwestern
experiments, using the same nuclear extracts as in EMSA,
there was a severe decrease of p97/DNA interaction in di¡er-
entiated cells at 7 and 15 days (Fig. 1B, lanes 2 and 3) com-
pared with undi¡erentiated cells (Fig. 1B, lane 1).
To explore whether the decrease in the amount of the
DNA-protein complex in di¡erentiated cells at 7 and 15
days correlates with L-type mRNA expression, we performed
RNase protection experiments on total RNA from undi¡er-
entiated (Fig. 1C, lane 1) and di¡erentiated Caco-2 cells (Fig.
1C, lanes 2 and 3). The levels of L-type mRNA increased
signi¢cantly during cell di¡erentiation. These data indicate
that in the human system the enhanced expression of L-type
mRNA during cell di¡erentiation re£ects the decreased bind-
ing of p97 to AldA-NRE, as previously shown in the murine
system during cell growth arrest [11].
3.2. Phosphatase treatment of nuclear extract from
di¡erentiated Caco-2 cells restores the binding e⁄ciency of
p97 to AldA-NRE
To determine whether the di¡erent DNA binding e⁄ciency
of p97 to AldA-NRE, observed in proliferating and di¡eren-
tiated cells, is caused by phosphorylation of the protein, we
treated nuclear extracts from Caco-2 cells with PAP prior to
the addition of labelled Neg1 probe. As shown in Fig. 2A,the
low binding activity of nuclear extracts from di¡erentiated
cells (lane 2) is remarkably increased after PAP treatment
for 10 and 20 min (lanes 4 and 6). The restored binding
activity of the di¡erentiated Caco cells after PAP treatment
is comparable to that of nuclear extracts from PAP-untreated
proliferating cells (lane 1) and from PAP-treated proliferating
cells (lanes 3 and 5). Furthermore, as shown in Fig. 2B, the
increased binding activity of nuclear extracts from di¡erenti-
ated Caco-2 cells after PAP treatment (compare lanes 7 and 2)
is abolished by inhibition of phosphatase activity with 4NPP.
The phosphatase inhibition by 4NPP is dose-dependent (1, 5
and 10 mM in lanes 3^5, respectively), and the highest con-
centration of 4NPP (lane 5) completely prevents the e¡ect of
PAP treatment (compares lanes 5 and 7).
Taken together these results demonstrate that phosphoryla-
tion of p97, occurring in di¡erentiated Caco-2 cells, decreases
its DNA binding activity.
3.3. Phosphorylation of p97 is mediated by protein kinase C
To verify whether PKC is involved in phosphorylation of
Fig. 2. E¡ect of phosphatase treatment on the binding activity in nuclear extracts from Caco-2 cells. A: Nuclear extracts from proliferating
(lanes 3 and 5) and di¡erentiated (lanes 4 and 6) Caco-2 cells were treated with PAP (0.12 U) for 10 min (lanes 3 and 4) or for 20 min (lanes
5 and 6) at 37‡C, prior to EMSA. Nuclear extracts from proliferating (lane 1) and di¡erentiated (lane 2) Caco-2 cells were incubated without
PAP at 37‡C for 20 min prior to EMSA, as control. The arrow indicates the speci¢c DNA-protein complex. F indicates the free probe; p indi-
cates proliferating cells ; d indicates di¡erentiated cells. B: Nuclear extracts from di¡erentiated Caco-2 cells were incubated with the phospha-
tase inhibitor 4NPP at concentrations of 1, 5 and 10 mM (lanes 3, 4 and 5, respectively) for 10 min, prior to the addition of PAP. Lanes 6
and 7: nuclear extracts from proliferating and di¡erentiated Caco-2 cells, respectively, treated with PAP at 37‡C for 20 min without the phos-
phatase inhibitor 4NPP. Nuclear extracts from proliferating (lane 1) and di¡erentiated (lane 2) Caco-2 cells were incubated without PAP at
37‡C for 20 min prior to EMSA, as control. The arrow indicates the speci¢c DNA-protein complex. F indicates the free probe; p indicates
proliferating cells ; d indicates di¡erentiated cells.
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p97, we treated proliferating NIH 3T3 cells with phorbol ester
TPA, which speci¢cally stimulates PKC activity at a concen-
tration of 120 ng/ml for 10 min, and downregulates it at a
concentration of 200 ng/ml for 24 h [13]. In experimental
conditions of PKC stimulation the p97 binding activity was
signi¢cantly decreased (Fig. 3, lane 3) compared with the
binding of NIH 3T3 cells not treated with TPA (lane 1).
Conversely, TPA-induced downregulation of PKC caused an
increase of p97 binding activity (lane 2). The presence of H7,
an inhibitor of PKC, caused an increase of p97 binding ac-
tivity in NIH 3T3 cells treated with TPA in conditions of
PKC stimulation (compare lane 4 versus lane 3).
Next, we demonstrate that p97 binding activity in prolifer-
ating NIH 3T3 cells (Fig. 4, lane 1) was inhibited by PKC
(Fig. 4, lane 2) and recovered by increasing amounts of PAP
(0.06 U in lane 4, and 0.12 U in lane 6); this is suggestive of
regulation of the DNA binding protein by phosphorylation.
Finally, we observed that PAP treatment of nuclear extracts
from proliferating NIH 3T3 cells leads to an increased binding
activity (compare lanes 3 and 5 versus lane 1); this suggests
that a fraction of repressor might be phosphorylated in pro-
liferating NIH 3T3 cells.
3.4. Transcriptional regulation of CAT reporter constructs is
a¡ected by phosphorylated/dephosphorylated forms of p97
To demonstrate that phosphorylation of p97 is involved in
L-type mRNA expression, we analysed NIH 3T3 mouse cells
constitutively expressing a chimeric L-type-CAT mRNA. We
generated several stably transfected clones, using the Lv-555
construct, previously described [8]. In transient transfection
experiments, this construct exhibited reduced transcriptional
activity, due to the silencing e¡ect of AldA-NRE [11]. To
modulate PKC activity, we treated a stable clone (Lv-555
clone 5), constitutively expressing Lv-555 construct, with
TPA.
Downregulation of PKC (by TPA treatment for 24 h at a
concentration of 200 ng/ml) led to a decrease of CAT tran-
scriptional activity in Lv-555 clone 5 compared with that of
TPA-untreated cells (22.1% versus 60.7% in Fig. 5). Con-
versely, PKC stimulation (by TPA treatment for 1 h at a
concentration of 10 ng/ml) caused a relevant induction of
CAT activity in Lv-555 clone 5 (108.1% versus 60.7% in
Fig. 5). TPA treatment was performed also with a stable mu-
tant clone (Lv-555 clone MN1), constitutively expressing the
Lv-555MutN1 construct. Previously, we found that the sub-
stitution of the binding motif (AGAGA) of AldA-NRE with
the CCGCG sequence in the Lv-555MutN1 construct reduces
Fig. 3. E¡ect of TPA treatment on the binding activity in NIH 3T3
cells. The 5P-end-labelled Neg1 probe was incubated with nuclear
extracts from NIH 3T3 cells (lane 1), from NIH 3T3 cells treated
with TPA (200 ng/ml) for 24 h (lane 2), from NIH3 T3 cells treated
with TPA (120 ng/ml) for 10 min (lane 3) and from NIH 3T3 cells
treated with H7 at a concentration of 50 WM for 20 min prior to
the addition of TPA (120 ng/ml for 10 min) (lane 4). The arrow in-
dicates the speci¢c DNA-protein complex. F indicates the free
probe.
Fig. 4. E¡ect of phosphatase on the binding activity in NIH 3T3
cells treated with TPA. Nuclear extracts from NIH 3T3 cells (lanes
3 and 5) and from NIH 3T3 cells treated with TPA (120 ng/ml for
10 min) (lanes 4 and 6) were incubated with 0.06 U of PAP (lanes
3 and 4) or with 0.12 U of PAP (lanes 5 and 6) for 20 min at
37‡C, prior to EMSA. Lanes 1 and 2: nuclear extracts from NIH
3T3 cells untreated and TPA-treated (120 ng/ml for 10 min), respec-
tively, without PAP. The arrow indicates the speci¢c DNA-protein
complex. F indicates the free probe.
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the binding activity and leads to an increased CAT transcrip-
tional activity [11]. Here, we demonstrate that the transcrip-
tional activity of the stable mutant Lv-555 clone MN1 was
not a¡ected by modulation of PKC activity. In fact, the rel-
ative CAT activity was similar in TPA-untreated and TPA-
treated cells (99.3% and 102.5% versus 100% in Fig. 5), thus
demonstrating that e¡ects exerted by TPA upon the interac-
tion between p97 and AldA-NRE require the wild-type AldA-
NRE motif.
These results indicate that the PKC-dependent phosphoryl-
ation of p97, leading to the displacement of p97 from Ald-
A-NRE, is the basic event that in vivo regulates the aldolase
A L-type promoter activity.
4. Discussion
Gene expression is actively repressed through silencers and
negative regulatory elements; the former, de¢ned ‘position-
independent regulatory elements’, direct an active repression
mechanism by interfering, usually, with general transcription
factors. The latter, de¢ned ‘non-classical, position-dependent
elements’, drive a passive repression mechanism by interacting
with auxiliary transcription factors [19]. Within the human
aldolase A pL promoter we have identi¢ed a negative regu-
latory element, AldA-NRE, that represses promoter activity
in an orientation-independent fashion, in the context of a
native and a heterologous promoter [8]. In this respect,
AldA-NRE belongs to the classical silencer family.
We previously showed that mouse AldA-NRE binds a 97-
kDa nuclear repressor protein and that this DNA-protein
interaction modulates the expression of aldolase A L-type
mRNA in a cell cycle-dependent fashion in NIH 3T3 cells
[11]. Here, we demonstrate that during the di¡erentiation of
human Caco-2 cells the increased expression of aldolase A L-
type mRNA is caused by a decreased binding of a 97-kDa
protein (p97) to AldA-NRE. Therefore, we have investigated
whether phosphorylation of the p97 repressor a¡ects its DNA
binding activity. We found that p97 is phosphorylated in dif-
ferentiated cells and that the phosphorylation leads to a de-
crease in binding activity (see Fig. 2) and to an increase in the
transcription of pL promoter (see Fig. 5). Post-translational
modi¢cation of transcription factors, often phosphorylation
events, is a rapid system with which to control gene induction
and repression in eukaryotes during proliferation/di¡erentia-
tion stages [20]. Data presented in this work con¢rm and
enlarge the notion that the a⁄nity of the protein/DNA inter-
action is generally decreased by phosphorylation.
There are several well-documented examples of transcrip-
tional activators whose function is modulated by phosphoryl-
ation [21]. To our knowledge, p97 is one of the few transcrip-
tional repressors whose binding activity is modulated by
phosphorylation. The ¢ndings that p97 is cell cycle-regulated
[11] and that its binding activity is modulated by phospho-
rylation (this work) suggest that p97 is a phosphorylation-
dependent transcriptional repressor regulated during the cell
cycle. Protein kinase C is one of the major regulators of cell
growth and cell proliferation [22,23]. Compelling evidence
points to a role for PKC isoenzymes as regulators linking
signal transduction pathways to the cell cycle machinery
[24,25]. Our data suggest that phosphorylation of p97 repress-
or is mediated by members of the PKC family. Indeed, PKC
downregulation caused an increase of p97/AldA-NRE bind-
ing, whereas stimulation of PKC activity by TPA provoked a
severe decrease of p97 binding activity (see Fig. 3). The re-
duced binding activity observed under conditions of PKC
activation was reversed in the presence of a PKC inhibitor
(H7) (see Fig. 3). Finally, we demonstrate that the in vivo
PKC-dependent phosphorylation of p97 repressor was the
event responsible for transcriptional regulation of the pro-
moter region harboring AldA-NRE in its 5P sequences. In
fact, clones stably expressing CAT mRNA driven by the al-
dolase A pL promoter showed decreased CAT activity when
PKC was downregulated, and increased CAT activity under
conditions of PKC stimulation (see Fig. 5). Our results, sum-
marised in a schematic model in Fig. 6, suggest that transcrip-
tional regulation of the AldA L-type promoter is mediated by
p97/AldA-NRE interaction and is modulated by PKC-de-
pendent phosphorylation of p97. However, at the moment
we do not know whether in vivo phosphorylation of p97 is
mediated directly by PKC, or other proteins are involved in
this pathway.
The isolation and cloning of p97 repressor protein will pro-
vide insights into the molecular mechanisms that regulate p97
Fig. 5. Transcriptional regulation of aldolase A-CAT constructs by
p97/AldA-NRE interaction in NIH 3T3 cells. Values represent rela-
tive CAT activities of the wild-type Lv-555 clone 5 compared with
that of the mutant Lv-555 clone MN1 arbitrarily taken as 100%.
The same results were obtained with at least two di¡erent stable
clones. Each value is mean þ S.D. from 3^5 independent experi-
ments. N.D.: not detected.
Fig. 6. Proposed scheme of the transcriptional regulation mediated
by the p97/AldA-NRE interaction.
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activity during the cell cycle and into the relationship between
cell cycle control and the PKC signal transduction pathway.
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